Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Prevalence, awareness, treatment and control of high blood pressure among Chinese rural population in Haimen, Jiangsu

Abstract

Nowadays, high blood pressure (HBP) is one of the most common chronic diseases in China. This survey aims to assess HBP prevalence, and related disease awareness, treatment and control among rural population in Haimen, Jiangsu province, China. A total of 7538 rural residents, aged over 18 years, from four randomly selected villages in Haimen, were selected to participate in the blood pressure examination in September 2010, the male-to-female ratio of participants was 1:1.57. In all, 2034 patients were diagnosed with HBP. The total crude prevalence of HBP was 26.98%, the overall standardized prevalence of HBP was 24.38%. Both male and female prevalence rates demonstrate ascending trend with age. Awareness, treatment and control rates among all patients were 68.34%, 61.46% and 27.43% respectively, whereas the corresponding rates in young group (18–44 years) were lower (50.94%, 35.85%, 24.53%). Improving treatment coverage and efficacy should be the focus of HBP prevention in rural areas in China.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365, 423 217–223.

    Article  Google Scholar 

  2. World Health Organization International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992.

    Article  Google Scholar 

  3. Martiniuk LC, Lee MY, Lawes MM, Ueshima H, Suh IL, Lam TH et al. Hypertension:its prevalence and population-attributable fraction for morality from cardiovascular disease in the Asia-Pacific. J Hypertens 2007; 25: 73–79.

    Article  CAS  Google Scholar 

  4. Li LM . Epidemiology 6th edn. People's Medical Publishing House: Beijing, China, 2007.

    Google Scholar 

  5. Winkelstein W, Kanor S, Ibrahim M, Sackett DL . Familial Aggregation of Blood Pressure. Humana Press: Totowa, NJ,USA, 2004.

    Google Scholar 

  6. Lu JP, Guo QQ, Zhang L, Wang W . Association between the G-protein β3 subunit C825T polymorphism with essential hypertension:a meta-analysis in Han Chinese population. Mol Biol Rep 2012; 39: 8937–8944.

    Article  CAS  Google Scholar 

  7. Mancia G, Guy DB, Anna D, Renata C, Robert F, Giuseppe G et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J. Hypertens 2007; 25: 1751–1762.

    Article  CAS  Google Scholar 

  8. Wang LD . National Nutrition and Health Survey in China (2002 report). People's Medical Publishing House: Beijing, China, 2005.

    Google Scholar 

  9. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY et al. A description on the Chinese national nutrition and health survey in 2002. Chinese J Epidemiol 2005; 26: 478–484.

    Google Scholar 

  10. Zhang M, Meng Y, Yong M, Yang YL, Liu YC, Dong CQ et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health 2011; 11: 301.

    Article  PubMed Central  Google Scholar 

  11. Han WY, Qin DH . Combied treatment with Adalat GITS and irbesartan to hypertension. J Clin Exp Med 2011; 10: 531.

    Google Scholar 

  12. Liu LS, Wang W, Yao CH . Guidelines for Prevention and Treatment of Hypertension in China (Skeleton in 2009). Chin J Hypertens 2010; 18: 11–30.

    Google Scholar 

  13. Peng Y, Wu M . Monitoring Report of Chronic Disease and Risk Factors in Jiangsu Province 1st edn. Nanjing Normal University Press: Nanjing, Jiangsu, China, 2013.

    Google Scholar 

  14. Whelton PK . Epidemiology of hypertension. Lancet 1994; 344: 101.

    Article  CAS  PubMed Central  Google Scholar 

  15. Pan XQ, Lv SR, Xiang QY, Wu M . Epidemiological study of hypertension in Jiangsu province. Jiangsu J Prevent Med 2010; 21: 17–19.

    Google Scholar 

  16. Ma YX, Zhang B, Wang HJ, Du WW, Su C, Zhai FY . The effect of alcohol consumption on prevalence of hypertension among adults residents from 9 Provinces of China. Chin J Prev Contr Chron Non-Commun Dis 2011; 19: 9–12.

    Google Scholar 

  17. Yan YX, Dong J, Wu LJ, Shao S, Zhang J, Zhang L et al. Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population. J Epidemiol 2013; 23: 389–395.

    Article  PubMed Central  Google Scholar 

  18. Lang XY, Nie SF, Qu KY, Peng XX, Wei S, Zhu GB et al. Evaluation of health-related quality of life among hypertensive patients in a rural area, PR China. J Hum Hypertens 2006; 20: 227–229.

    Article  Google Scholar 

  19. Shao S, Zhao F, Wang J, Feng L, Lu X . The ecology of medical care in beijing. PLoS ONE 2013; 8: e82446.

    Article  PubMed Central  Google Scholar 

  20. Ling RE, Liu F, Lu XQ, Wang W . Emerging issues in public health: a perspective on China's healthcare system. Public Health 2010; 125: 9–14.

    Article  PubMed Central  Google Scholar 

  21. Sun Z, Han X, Zheng L, Zhang X, Li J, Hu D et al. Subtypes of hypertension and risk of stroke in rural Chinese adults. Am J Hypertens 2014; 27: 193–198.

    Article  PubMed Central  Google Scholar 

  22. Huang J, Wildman RP, Gu D, Muntner P, Su S, He J . Prevalence of isolated systolic and isolated diastolic hypertension subtypes in China. Am J Hypertens 2004; 17: 955–962.

    Article  PubMed Central  Google Scholar 

  23. Fang XH, Zhang XH, Yang QD, Dai XY, Su FZ, Rao ML et al. Subtype hypertension and risk of stroke in middle-aged and older Chinese: a 10-year follow-up study. Stroke 2006; 37: 38–43.

    Article  PubMed Central  Google Scholar 

  24. Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X et al. Hypertension subtype and risk of cardiovascular disease in Chinese adults. Circulation 2008; 118: 1558–1566.

    Article  PubMed Central  Google Scholar 

  25. Reynolds K, Gu DF, Muntner P, Wu XG, Chen J, Huang GY et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 21: 1273–1281.

    Article  CAS  PubMed Central  Google Scholar 

  26. Zhai Y, Hu JP, Kong LZ, Zhao WH, Chen CM . Economic burden of coronary heart disease and stroke attributable to hypertension in China. Chin J Epidemiol 2006; 27: 744–747.

    Google Scholar 

  27. Guo JZ . The treatment of hypertensive crisis in old. Chinese Journal of Multiple Organ Diseases in the Elderly 2008; 7: 343–347.

    Google Scholar 

Download references

Acknowledgements

We thank Wei-Gen Lu and Jian Qing (Haimen Health Bureau) and Haimen Center for Disease Control and Prevention for assistance in the investigation, and we also thank Dr Jing Xiao (Department of Biostatistics, Nantong University) for her comments with data analysis. In addition, we also thank China’s Rural Health Development Program funded by Management of World Bank.

Ethics Approval

The study was reviewed and approved by the Institutional Review Board (IRB) of the Ethics Committee of Hospital Affiliated to Nantong University. The objectives and the procedure of the study, and potential risks and benefits of participating in the study were given to potential participants during the recruitment of study subjects. Oral informed consents were obtained from all subjects participated in the survey.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S-Y Jiang or X Zhuang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, T., Xian, Y., Mao, HM. et al. Prevalence, awareness, treatment and control of high blood pressure among Chinese rural population in Haimen, Jiangsu. J Hum Hypertens 30, 225–230 (2016). https://doi.org/10.1038/jhh.2015.107

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.107

This article is cited by

Search

Quick links